These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6374223)

  • 1. [ABH isoantigen of superficial urothelial tumor and carcinoma in situ of the bladder by the avidin-biotin peroxidase complex(ABC) method].
    Sasaki K
    Nihon Hinyokika Gakkai Zasshi; 1983 Aug; 74(8):1326-38. PubMed ID: 6374223
    [No Abstract]   [Full Text] [Related]  

  • 2. [The study of ABH isoantigen and T (Thomsen-Friedenreich) antigen of superficial urothelial tumor].
    Sasaki K
    Hokkaido Igaku Zasshi; 1984 Nov; 59(6):679-89. PubMed ID: 6530208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The study of the ABH isoantigen of bladder tumors].
    Fukatsu H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Takamura T; Yamada Y; Nishikawa E
    Hinyokika Kiyo; 1987 Jun; 33(6):857-63. PubMed ID: 3314420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of blood group surface antigens of urinary bladder tumours using monoclonal antibodies with the avidin-biotin complex technique.
    Tan LB; Chiang C; Huang CH; Lin LM
    Int Urol Nephrol; 1992; 24(3):255-64. PubMed ID: 1399382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modified immunoperoxidase method for the detection of ABH tissue isoantigens in patients with bladder carcinoma.
    Stul MS; Logghe GN; Bergmans GB; Vanvuchelen JK
    Exp Pathol; 1985; 27(2):119-22. PubMed ID: 3888650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ABH blood group isoantigen as a prognostic factor in transitional cell bladder carcinoma.
    Malmström PU; Busch C; Norlen BJ; Andersson B
    Scand J Urol Nephrol; 1988; 22(4):265-70. PubMed ID: 3238331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. III. Detection by PAP method and a classification of staining pattern].
    Nasu Y; Kumon H; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1984 May; 75(5):739-43. PubMed ID: 6208400
    [No Abstract]   [Full Text] [Related]  

  • 8. Visualization of urothelial blood group isoantigens A and B using direct biotin-labeled antibodies and avidin-biotin-peroxidase complex.
    Lin CW; Fujime M; Kirley SD; Prout GR
    J Histochem Cytochem; 1984 Dec; 32(12):1139-43. PubMed ID: 6209329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of ABH antigenicity of random mucosal biopsies and transitional cell carcinoma of the urinary bladder.
    Jakse G; Hofstädter F
    Eur Urol; 1983; 9(2):97-101. PubMed ID: 6852091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood group isoantigen deletion in carcinoma in situ of the urinary bladder.
    Weinstein RS; Alroy J; Farrow GM; Miller AW; Davidsohn I
    Cancer; 1979 Feb; 43(2):661-8. PubMed ID: 421187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The study on cell surface antigens in epithelial tumor of the upper urinary tract: ABH-isoantigen and Thomsen-Friedenreich antigen.
    Fukatsu H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Nishikawa E; Yamada Y; Satoh T
    Hinyokika Kiyo; 1989 Jun; 35(6):949-54. PubMed ID: 2801395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABH cell surface isoantigens in invasive bladder carcinoma associated with schistosomiasis.
    El Adl MM; Yamase HT; Nieh PT; Mostofa AS; Hinz CF; Walzak MP
    J Urol; 1984 Feb; 131(2):249-51. PubMed ID: 6366249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of ABH antigens and CEA for the prognosis of urothelial tumors].
    Hofstädter F; Jakse G
    Wien Klin Wochenschr; 1982 Jul; 94(14):366-8. PubMed ID: 7147976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood group isoantigens and bladder cancer. An overview.
    Srinivas V; Khan SA
    Urol Int; 1985; 40(4):233-4. PubMed ID: 3901475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of the A, B and H isoantigens in single transitional carcinoma cells.
    Borgström E; Wahren B
    J Urol; 1985 Jul; 134(1):199-202. PubMed ID: 3892047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prediction of invasive potential in superficial transitional cell carcinoma of the bladder.
    Finan PJ; Anderson JR; Doyle PT; Lennox ES; Bleehen NM
    Br J Urol; 1982 Dec; 54(6):720-5. PubMed ID: 6758916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isoantigens ABH in bladder tumors as an indicator of malignant potential (author's transl)].
    Kumon H; Asahi T; Morioka M; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1980 Jul; 71(7):767-74. PubMed ID: 7420804
    [No Abstract]   [Full Text] [Related]  

  • 18. ABH blood group isoantigen expression in breast carcinomas--an immunohistochemical evaluation using monoclonal antibodies.
    Lee AK; DeLellis RA; Rosen PP; Saigo PE; Gangi MD; Bagin R; Groshen S; Wolfe HJ
    Am J Clin Pathol; 1985 Mar; 83(3):308-19. PubMed ID: 2579540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. II. Results of a long-term follow-up and technical problems].
    Kumon H; Nasu Y; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1984 May; 75(5):731-8. PubMed ID: 6492527
    [No Abstract]   [Full Text] [Related]  

  • 20. ABH isoantigens, histology and DNA ploidy in 36 consecutive patients with transitional cell bladder cancer. Status of tumor and biopsies taken from visually normal urothelium.
    Borgström E; Nyman C; Lönn M
    Urol Res; 1987; 15(4):199-202. PubMed ID: 3672667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.